BSE · CHOKSILA

Choksi Laboratories Ltd.

Sector: Healthcare · ISIN: INE493D01013

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#2,717

of 5,004 stocks

▼ 131W

Peak #2,704 · 21 Sep 2026

Choksi Laboratories Ltd. is a microcap company in the Healthcare space and carries a steep earnings multiple that prices in strong future growth, is growing revenue at a solid clip, and posts a modest return on equity. Ownership as of Jun 2026.

Market Cap

128.09 Cr

P/E Ratio

65.21

P/B Ratio

5.01

ROE

7.68%

ROCE

10.77%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q2 2025-26
Revenue	12.06 Cr	12.82 Cr	10.82 Cr	11.12 Cr
Net Profit	58.24 L	1.03 Cr	31.04 L	24.21 L
EPS	0.84	1.47	0.45	0.35
Operating Profit	1.33 Cr	1.81 Cr	93.39 L	1.26 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

31.48%

Public

68.52%

PUBLIC BREAKDOWN

FII

7.02%

Individuals

49.84%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-Date	Type	Details
27 Aug 2001	Dividend	NIL Dividend - Rs. - 0.0000

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs